regulations
User account blocked after policy violation
Discover key strategies from the 2026 Pharmacists Convention on policy and AI to enhance operations and outcomes for independent pharmacists.
User Blocked After Repeated Policy Violations
Isatuximab approval in the EU marks the first subcutaneous Sarclisa delivery via the CirCLIQ injector, expanding multiple myeloma treatment options across Europ
User access denied after system block
Medicare’s 2.5% dermatology reimbursement increase for 2026 falls short, leaving clinics struggling with rising costs and denied user access.
Website blocks users from accessing content
Health plans are blocking users from content. Learn how new Medicare changes impact formulary access and patient care.
User access restricted after policy breach
The FTC settlement with Caremark and Zinc Health targets pharmacy benefit managers to lower insulin costs and improve transparency for consumers.
User access denied after system block
The U.S. Medicare drug pricing policy may cut costs by matching prices in other wealthy nations, reshaping pharmaceutical research priorities.
User access denied after policy breach
Dermatologists propose ending routine blood tests for isotretinoin patients without risk factors to streamline acne treatment.
User Blocked by Service
New PBM regulations in 2026 enhance transparency. Learn how industry changes impact healthcare practices.